$KRNY

Kearny Financial Corp. (KRNY): Results of Operations and Financial Condition

Kearny Financial Corp. (KRNY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 krny-20260630xexx991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE July 23, 2026 For further information contact: Keith Suchodolski, Senior Executive Vice President and Chief Operating Officer, or Sean Byrnes, Executive Vice President and Chief Financial Offic

Original reporting
Published Jul 23, 2026, 12:39 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 1:02 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$KRNY
Bullish
medium confidence
Mentioned
$KRNY
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$KRNYBullishMed
01

Why it matters

Traders can reassess KRNY’s rate sensitivity and earnings quality using disclosed net interest margin, loan/deposit trends, and the stated dividend timing. The filing also flags non-recurring quarter items that may affect normalization.

02

Market read

A concrete earnings and dividend disclosure for a regional bank, with specific NIM, loan mix, and balance-sheet movements that can influence valuation and near-term positioning.

03

What to watch

Non-recurring items (discrete tax charge, severance, OREO acquisition expense) impacted the quarter, so normalized earnings power may differ from headline EPS.

Relevance 7/10Novelty 7/10Timing: today’s SEC 8-K release, dividend payable Aug. 26 with record date Aug. 12

Background

This is an SEC Form 8-K (Item 2.02) with Exhibit 99.1 reporting fourth quarter and fiscal year ended June 30, 2026 results for Kearny Financial Corp.

Company-level read

Ticker impact

$KRNYBullishMedium confidence
Context

Kearny Financial reported FY2026 net income of $36.3M ($0.57/diluted) and declared a $0.11/share quarterly cash dividend payable Aug. 26, 2026.

Expected impact

Moderately positive bias for KRNY around the dividend and earnings details, with focus on net interest margin expansion and loan growth versus deposit softness.

Evidence & confidence

The filing includes multiple concrete datapoints (net income, EPS, NIM, assets/loans/deposits) and a specific dividend schedule, but it is not a guidance raise or capital action beyond the dividend.

Market effects

Adds another data point on small-bank profitability drivers, especially net interest margin expansion and loan mix remixing.

Highlights growth and deposit strategy in New York markets via specialty deposits and corporate banking recruitment.

Limited global impact; primarily relevant to US regional bank sentiment and rate-sensitive earnings expectations.

Counterpoint

Quarterly net income fell versus the prior quarter, and deposits declined slightly, so the dividend and FY strength may not fully offset near-term funding pressure.

Key entities

  • Kearny Financial Corp.

    Reports FY2026 and Q4 ended June 30, 2026 results and declares a $0.11/share quarterly cash dividend.

  • Kearny Bank

    Operating bank referenced as the entity behind the holding company’s results.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.